Literature DB >> 6416451

Bronchopulmonary infection due to Branhamella catarrhalis.

D T McLeod, F Ahmad, J T Power, M A Calder, A Seaton.   

Abstract

Over six months Branhamella catarrhalis was isolated in pure culture from the sputum of 81 patients with symptoms of acute respiratory tract infection. Of 38 patients who were infected in the community, over half required admission to hospital. The remaining 43 patients acquired the infection in hospital. Forty one of the 81 isolates produced beta-lactamase, 24 of these being hospital acquired infections. As a result 40% of patients who were treated with ampicillin did not respond. Most patients had chronic lung diseases or lung cancer or were taking corticosteroids. Three patients died and one required assisted ventilation; strains producing beta-lactamase were isolated in each case. Acute bronchitis developed in one previously healthy young non-smoker. It is concluded that B catarrhalis is an important pathogen of the lower respiratory tract which should be reported, and strains producing beta-lactamase should be identified. Otherwise, treatment with inappropriate antibiotics may result in increased morbidity or mortality.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416451      PMCID: PMC1549671          DOI: 10.1136/bmj.287.6403.1446

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria.

Authors:  K Montgomery; L Raymundo; W L Drew
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

2.  Novel beta-lactamase from Branhamella catarrhalis.

Authors:  A B Hoi-Dang; C Brive-Le Bouguenec; M Barthelemy; R Labia
Journal:  Ann Microbiol (Paris)       Date:  1978-10

3.  Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host.

Authors:  D J McNeely; C S Kitchens; R M Kluge
Journal:  Am Rev Respir Dis       Date:  1976-08

4.  Branhamella catarrhalis infection of the lower respiratory tract: reliable diagnosis by sputum examination.

Authors:  P E Thornley; J Aitken; C J Drennan; J MacVicar; N J Slevin
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

5.  Branhamella catarrhalis in respiratory secretions: clinical correlation in 16 cases.

Authors:  A von Graevenitz; R R Rathbone
Journal:  South Med J       Date:  1981-09       Impact factor: 0.954

6.  Rapid carbohydrate utilization test for the identification of Neisseria gonorrhoeae.

Authors:  H Young; I C Paterson; D R McDonald
Journal:  Br J Vener Dis       Date:  1976-06

7.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04

8.  Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.

Authors:  G V Doern; K G Siebers; L M Hallick; S A Morse
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

  8 in total
  27 in total

1.  Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center.

Authors:  H Yano; M Suetake; A Kuga; K Irinoda; R Okamoto; T Kobayashi; M Inoue
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia.

Authors:  C DiGiovanni; T V Riley; G F Hoyne; R Yeo; P Cooksey
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

3.  Characterisation of Branhamella catarrhalis and differentiation from Neisseria species in a diagnostic laboratory.

Authors:  F Ahmad; H Young; D T McLeod; M J Croughan; M A Calder
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

4.  Increase in bronchopulmonary infection due to branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; S Capewell; M J Croughan; M A Calder; A Seaton
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-26

5.  Lack of immunoglobulin A1 protease production by Branhamella catarrhalis.

Authors:  D T McLeod; M J Croughan; F Ahmad; R P Brettle; M A Calder
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

6.  Pneumonia due to Branhamella catarrhalis.

Authors:  S Capewell; D T McLeod; M J Croughan; F Ahmad; M A Calder; A Seaton
Journal:  Thorax       Date:  1988-11       Impact factor: 9.139

7.  Pulmonary thin-section CT findings in acute Moraxella catarrhalis pulmonary infection.

Authors:  F Okada; Y Ando; T Nakayama; S Tanoue; R Ishii; A Ono; M Watanabe; H Takaki; T Maeda; H Mori
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

8.  Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.

Authors:  F Ahmad; D T McLeod; M J Croughan; M A Calder
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 9.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

10.  Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response.

Authors:  D T McLeod; F Ahmad; M J Croughan; M A Calder
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.